John Carreyrou, the Wall Street Journal reporter who broke the story, chronicles the rise and fall of Theranos, the blood-testing company whose charismatic founder Elizabeth Holmes promised to revolutionize medicine but instead built one of the biggest frauds in Silicon Valley history. Holmes claimed her technology could run hundreds of tests from a single drop of blood, attracting billions in investment and partnerships with major pharmacy chains. Carreyrou reconstructs how Holmes and her partner Sunny Balwani created a culture of secrecy and intimidation, threatening employees who raised concerns and deceiving investors, regulators, and patients. The book follows whistleblowers who risked careers and faced legal threats to expose the fraud, as well as patients who received inaccurate test results with potentially life-threatening consequences. Carreyrou examines how Holmes's powerful board, which included former Secretaries of State and Defense, lent credibility while failing to provide oversight. He traces the company's downfall as the Journal's reporting triggered investigations that revealed Theranos's technology never worked as claimed. The book illuminates Silicon Valley's culture of fake-it-till-you-make-it entrepreneurship and the consequences when that ethos is applied to medical devices. Carreyrou's gripping narrative combines investigative journalism with character study, exploring how ambition, deception, and a culture of hype combined to endanger lives while captivating investors and the media.